MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'diabetes drug'. Sat, 03 Sep 2011 02:11:16 +0100 http://www.medworm.com/index.php?rid=5028220&cid=t_135852_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fmeta-analyses-and-a-capricious-drug-approval-process-the-actos-and-avandia-stories%2F2011.07.13 Both Germany and France have now suspended the marketing of Actos (pioglitazone) due to concerns of a link between Actos and bladder cancer. Though we have known about bladder cancer concerns for some time, these recent concerns about the bladder cancer link stem from a recent report analyzing the FDA’s Adverse Event Reporting System (AERS), which found that 93 cases of cancer were recorded between 2004 and 2009 in patients treated with antidiabetic drugs, of which 31 patients were treated with pioglitazone, representing a statistically significant increased risk of bladder cancer (ROR 4.30, 95% confidence interval, 2.82-6.52; P less than 0.0001). Interestingly, the FDA announced that it was going to look into the link between Actos and bladder cancer only a few days before it made i... Better Health blogs http://www.medworm.com/rss/comments.php?id=5028220 Wed, 13 Jul 2011 19:00:00 +0100 5028220 http://www.medworm.com/index.php?rid=4960328&cid=t_135852_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FBKp9JbQ2S5I%2F Good morning, everyone. How are you today? Getting ready for those meetings and deadlines? We relate. There is much to do here on the Pharmalot corporate campus - reading, writing, chasing down interesting people. To prepare, we are brewing that reliable cup of stimulation - our flavor today is Rain Forest Nut. Feel free to join us. And to get things started, here are some tidbits. Have a good one and stay in touch… Bristol And Astra Diabetes Pill Faces Safety Hurdles (Bloomberg News) Biotechs Want Faster Drug Approvals (Boston Globe) Lilly CEO Blames Tax Laws And Immigration For Slower Innovation (Bloomberg News) Glaxo Ordered To Give Plaintiff Lists To United Health (Legal Intelligencer) Too Many UK Patients Are Prescribed Risky Drugs (Pharma Times) Abbott Labs Plant Closure Delaye... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4960328 Thu, 23 Jun 2011 11:54:26 +0100 4960328 http://www.medworm.com/index.php?rid=4952833&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fnews.consumerreports.org%2Fhealth%2F2011%2F06%2Ffda-warns-of-bladder-cancer-risk-with-actos.html The diabetes drug pioglitazone (Actos) increases the risk of bladder cancer in people who take it for a year or longer, the Food and Drug Administration announced yesterday. The warning applies to all drugs containing pioglitazone, including Actoplus Met, Actoplus Met XR, and Duetact. The FDA said an ongoing study involving more than 193,000 people 40 or older with type 2 diabetes found that those who took Actos for more than a year had a 40 percent higher risk of developing bladder cancer. France banned the drug last week after a study that followed 1.5 million people with diabetes also found an increased risk of bladder cancer, particularly in men. Signs of bladder cancer include blood or red color in your urine, urgent need to urinate or pain while urinating, and pain in your back or... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=4952833 Fri, 17 Jun 2011 16:15:00 +0100 4952833 http://www.medworm.com/index.php?rid=4847949&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fnews.consumerreports.org%2Fhealth%2F2011%2F05%2Ffda-says-no-to-avandia-in-drugstores.html You won’t be able to get the type 2 diabetes drug Avandia (rosiglitazone) in pharmacies after November 18. That’s when new Food and Drug Administration restrictions will take effect, with the aim of reducing the risk of heart attacks caused by the medication. Instead, you’ll have to enroll in a special program to get rosiglitazone and combination products that contain it by mail order. Last year, the FDA limited the use of Avandia, Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride) to people already on one of those medications and those whose diabetes is not controlled by other drugs. The new restrictions announced this week require both patients and doctors to enroll in the Avandia-Rosiglitazone Medicines Access Program. Certified phar... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=4847949 Fri, 20 May 2011 14:05:00 +0100 4847949 http://www.medworm.com/index.php?rid=4636432&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fnews.consumerreports.org%2Fhealth%2F2011%2F03%2Flifestyle-changes--not-actos--still-best-bet-for-prediabetes.html A study out this week in the New England Journal of Medicine suggests that people who have blood glucose levels that are elevated but not yet quite diabetic should consider taking a drug usually reserved for those with full-blown diabetes. We disagree. The study found that after about two years of follow-up, people who took pioglitazone (Actos) had a 72 percent reduction in their blood glucose measurements compared with those who took a placebo. In addition, for every 100 people who took the drug only about two developed diabetes, compared with about eight out of 100 who took the placebo. Finally, Actos lowered blood pressure and raised HDL (good) cholesterol. So what's the problem? The drug caused weight gain (an average of about 8 pounds) as well as edema, a condition in which the bo... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=4636432 Fri, 25 Mar 2011 15:15:00 +0100 4636432 http://www.medworm.com/index.php?rid=4592387&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2011%2F03%2Fmajor-review-of-166-studies-says-best-diabetes-drug-is-cheapest-.html A comprehensive review published online today in the Annals of Internal Medicine concludes that the best diabetes drug is one of the oldest and cheapest diabetes drugs: metformin. That medication costs about 35 cents a pill when bought as a generic, compared with $6.42 a pill for Januvia (sitagliptin), one of the newest diabetes on the market. Moreover, metformin lowers blood sugar at least as well as all other drugs and better than some others, notably Actos (pioglitiazone) and Avandia (rosiglitazone). It also lowers LDL (bad) cholesterol more effectively than most other diabetes drugs. To top it all off, the drug is less likely to cause some of the serious side effects that plague diabetes medications, including dangerously low blood-sugar levels, fractures, heart failure, and weight ga... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=4592387 Mon, 14 Mar 2011 21:01:00 +0100 4592387 http://www.medworm.com/index.php?rid=4495197&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2011%2F02%2Fstatins-one-in-four-take-statins-more-people-than-ever-take-cholesterol-lowering-statins.html Roughly one in four adults 45 and older now take a cholesterol-lowering statin drug, compared with just one in 50 about 15 years ago, according to a report released this week by the Centers for Disease Control and Prevention. But that doesn’t mean the drugs are for everyone, and as we've previously reported, some experts worry that too many people are being put on the drugs. Statins—such as atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor and generic)—can reduce the risk of a heart attack and premature death in people who have a history of heart disease or at high risk of it. But they provide less benefit to other people, perhaps especially low-risk women. That’s one reason our new Ratings of heart-screening tests recommend routine cholesterol screening f... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=4495197 Fri, 18 Feb 2011 19:12:54 +0100 4495197 http://www.medworm.com/index.php?rid=3998973&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2010%2F09%2Favandia-decision-fda-rules-on-diabetes-drug-heart-risks-glaxosmithkline-drug-safety.html The Food and Drug Administration Thursday limited the diabetes drug rosiglitazone (Avandia, Avandamet, and Avandaryl) to people who can't use other medications due to concerns it could cause a heart attack or stroke. The FDA's action falls short of its counterpart across the ocean, the European Medicines Agency, which decided Avandia was too risky and have recommended that it be withdrawn from the market. We have long advised that Avandia carries too many risks and should be avoided if at all possible. “The evidence we have to date does not support the use of Avandia as a first, second, or even third line drug for treating type 2 diabetes,” according to John Santa, M.D., M.P.H., Director, Consumer Reports Health Ratings Center. “This latest effort on the part of the FDA to d... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=3998973 Thu, 23 Sep 2010 17:03:40 +0100 3998973 http://www.medworm.com/index.php?rid=3965412&cid=t_135852_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fdo-drug-companies-pay-attention-to-herbal-medicine%2F2010.09.13 I’m only a monthly contributor here, but between being a Science Based Medicine (SBM) reader and having my own blogs, I often grow weary of the blind criticism that researchers and drug companies couldn’t care less about traditional folk medicines as drug products. My laboratory spends every single day working on natural product extracts in the search for compounds that may have selective effectiveness against cancer. So this is a bit of a sore spot for me. Two [recent] papers from Cancer Prevention Research on the potential anticancer effects of a diabetes drug (see Nathan Seppa’s story here) remind me to tell the story of a Middle Ages European herbal medicine used to treat polyuria that gave rise to one of the most widely prescribed drugs in the world, metformin (Glucophage ... Better Health blogs http://www.medworm.com/rss/comments.php?id=3965412 Mon, 13 Sep 2010 18:00:21 +0100 3965412 http://www.medworm.com/index.php?rid=3816762&cid=t_135852_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F8wCoe6kSHgk%2F Hello, everyone, and welcome to another busy day. This may be the sleepy stretch of summer, but the world is spinning as quickly as ever, yes? And so we must prepare for still more deadlines and meetings. As you do the same, here are a few tidbits to help you along. So grab a cup of something stimulating and dig in. Have a good one and stay in touch… Allergan CEO Says Company Is Not For Sale (Dow Jones) Sanofi Shareholders Want Genzyme For $19 Billion (Reuters) Alcon Shareholders Told To Vote No On Novartis Slate (PharmaTimes) FDA Guidance Aims To Cut Residual Drug In Patches (InPharma Technologist) Will Botox Be Approved For Migraines? (Reuters) Diabetes Drugs Dispensed In UK Zooms By 43% (PharmaTimes) AstraZeneca VAT Voucher Case Rings Alarm Bells (Accountancy Age) KV Pharma Gets N... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3816762 Tue, 03 Aug 2010 11:55:41 +0100 3816762 http://www.medworm.com/index.php?rid=3780355&cid=t_135852_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fbreast-cancer-diagnosis-and-treatment-can-women-trust-it%2F2010.07.22 The news wasn’t good this week for women concerned about breast cancer. First came the story that some women were diagnosed with breast cancer, very early stage, had treatment –- including disfiguring surgery -– and then found out they never had cancer in the first place. The pathologist goofed, maybe even a second pathologist also misread the biopsies. How does this happen? Not surprisingly it comes back to the clinical experience of the doctor. Properly diagnosing breast cancer, whether through radiology scans or pathology biopsies is not always easy. And in many communities the general radiologists and pathologists just don’t have enough specialized experience. This leads to mistakes, especially when the suggestions of possible cancer are subtle and minute. (more…) ... Better Health blogs http://www.medworm.com/rss/comments.php?id=3780355 Thu, 22 Jul 2010 21:00:33 +0100 3780355 http://www.medworm.com/index.php?rid=3753814&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2010%2F07%2Favandia-fda-panel-divided-on-avandia-diabetes-drug-avandia-avandia-risks.html A panel of experts convened by the Food and Drug Administration said Wednesday the type 2 diabetes drug Avandia increases the risk of heart attacks, but was divided on whether the medication should be withdrawn from the market. This could make a final decision difficult for the FDA, which does not have to follow the advice of its advisory panels but often does. While most of the panel agreed Avandia posed an increased risk of heart attacks compared to other diabetes medications, including a similar type of drug called Actos, they were divided on whether additional warnings and limitations on its use would be enough to curtail its potential hazards. Twelve panel members voted that it should be withdrawn from the market. But 10 voted to allow it to continue to be sold with additional warni... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=3753814 Thu, 15 Jul 2010 00:19:00 +0100 3753814 http://www.medworm.com/index.php?rid=3750052&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2010%2F07%2Favandia-warning-diabetes-drug-avandia-on-the-chopping-block-at-the-fda-metformnin-to-treat-diabetes.html We have long recommended that consumers steer clear of the type 2 diabetes drug Avandia (rosiglitazone) because it can increase the risk of heart failure and could possibly trigger heart attacks. Beginning today, the medication faces what could be its final trial, as a committee of experts convened by the Food and Drug Administration will consider whether the drug’s safety problems are severe enough to warrant increased restriction of its use or removal from the market altogether. The evidence against Avandia has continued to mount over the last several months. The two most recent studies found that Avandia is linked to an increased risk of heart attacks, strokes and death. And, an internal analysis conducted by FDA officials that was released in February concluded the drug causes hear... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=3750052 Tue, 13 Jul 2010 15:03:50 +0100 3750052 http://www.medworm.com/index.php?rid=3746739&cid=t_135852_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Ffor-patients-does-the-fda-play-fair%2F2010.07.12 They have a tough job, those government doctors, scientists, and bureaucrats who are charged with assessing the safety and effectiveness of proposed new medical products. As you know, they rely largely on studies presented by the applicants. The Food and Drug Administration (FDA) has the power to not approve a new drug or product or even pull it off the market. Right now it is considering limiting or pulling GlaxoSmithKline’s (GSK) diabetes drug, Avandia, because of newly discovered data that it may have caused heart attack in some patients –- data mysteriously not shown in GSK’s own studies. If the drug is pulled it will cost GSK billions of dollars in lost revenue but, from the FDA’s point-of-view, it will be protecting the public. And, after all, there are safer diabetes drugs ... Better Health blogs http://www.medworm.com/rss/comments.php?id=3746739 Mon, 12 Jul 2010 18:00:41 +0100 3746739 http://www.medworm.com/index.php?rid=3710557&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2010%2F06%2Favandia-diabetes-drug-knockout-blow-for-diabetes-drug-avandia-rosiglitazone-drug-safety.html Two new studies could spell the end for the controversial type 2 diabetes drug, rosiglitazone (Avandia), which previous research has linked to heart problems. The new studies released Monday found that Avandia increases the risk of heart attacks, strokes and death, and lend further support to our recommendation in our Best Buy Drugs report that you should avoid the drug if possible. In the first study, published in the Journal of the American Medical Association, a team of researchers led by David Graham, MD, of the Food and Drug Administration, analyzed Medicare records of more than 227,000 people 65 or older who took either Avandia or another diabetes drug, pioglitazone (Actos). They found that those who were on Avandia had an increased risk of stroke, heart failure and death. In the s... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=3710557 Tue, 29 Jun 2010 14:45:00 +0100 3710557 http://www.medworm.com/index.php?rid=3298317&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2010%2F02%2Favandia-safety-leaked-fda-documents-called-for-withdrawal-of-diabetes-drug-avandia-treating-diabetes.html If you need a drug for type 2 diabetes, we’ve long advised that a time-tested older medication called metformin is your safest bet and documents from the Food and Drug Administration released over the weekend underscore why. The controversial diabetes drug Avandia already carries a warning that it can cause heart failure, but some FDA officials think the medication also causes heart attacks and should be pulled from the market. According to internal reports* (released by the Senate Finance Committee), FDA officials speculate that if patients on Avandia were switched to a different drug called Actos, 500 heart attacks and 300 cases of heart failure could be prevented every month.The FDA documents were discovered in a two-year investigation into Avandia by the Senate Committee on Finance, ... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=3298317 Mon, 22 Feb 2010 22:07:36 +0100 3298317 http://www.medworm.com/index.php?rid=2989101&cid=t_135852_86_f&fid=36669&url=http%3A%2F%2Ffadelibrary.wordpress.com%2F2009%2F11%2F13%2Fthe-lancet-2009-volume-374-issue-9702%2F Contents Page Fade Fave: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Fade Skinny: In the 2·8 years of the Diabetes Prevention Program (DPP) randomised clinical trial, diabetes incidence in high-risk adults was reduced by 58% with intensive lifestyle intervention and by 31% with metformin, compared with placebo. This 10 year follow-up finds that incidences in the former placebo and metformin groups fell to equal those in the former lifestyle group, but the cumulative incidence of diabetes remained lowest in the lifestyle group. Prevention or delay of diabetes with lifestyle intervention or metformin can persist for at least 10 years. (Print Subscription Held by the Fade Library) Posted in Current Awareness, Journals Tagged: Cur... Fade Library blogs http://www.medworm.com/rss/comments.php?id=2989101 Fri, 13 Nov 2009 12:08:47 +0100 2989101 http://www.medworm.com/index.php?rid=2958842&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2009%2F11%2Fdiabetes-drug-byetta-poses-kidney-risks-treatments-for-diabetes-diabetes-drug-treatments-.html People with diabetes may want to use extra caution with the drug exenatide (Byetta). The Food and Drug Administration Monday added a warning about the risk of potentially life-threatening kidney problems to the package insert of the injectable diabetes drug. The FDA said that from April 2005 through October 2008 it received 78 reports of kidney function problems, including 62 cases of kidney failure and four deaths, in people taking Byetta. The drug can cause nausea, vomiting, and diarrhea, and these might have contributed to the kidney problems, the FDA said. If you or a loved one are taking Byetta, you should look for any symptoms that could indicate kidney problems. These include changes in urine color, frequency of urination or the amount of urine, unexplained swelling of the han... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=2958842 Wed, 04 Nov 2009 15:14:39 +0100 2958842 http://www.medworm.com/index.php?rid=2832141&cid=t_135852_87_f&fid=38113&url=http%3A%2F%2Fblogs.consumerreports.org%2Fhealth%2F2009%2F09%2Fjanuvia-janumet-pose-dangerous-risk-fda-says.html The Food and Drug Administration today warned that two diabetes medicines--sitagliptin (Januvia) and sitagliptin/metformin (Janumet) have been associated with dangerous cases of swelling of the pancreas. The FDA notified healthcare professionals and also changed the drugs’ labeling (package insert) to reflect the pancreas risk. The pancreas aids in digestion and also in regulating blood sugar levels. The agency said it had received reports of 88 cases of acute pancreatitis between October 2006 and February 2009, including many cases that were severe enough to require hospitalization and four people that were admitted to the intensive care unit. The FDA recommends that healthcare professionals monitor patients carefully for this problem in patients taking either Januvia or Janumet. In ... Consumer Reports Health Blog blogs http://www.medworm.com/rss/comments.php?id=2832141 Fri, 25 Sep 2009 17:45:04 +0100 2832141 http://www.medworm.com/index.php?rid=2325199&cid=t_135852_134_f&fid=34841&url=http%3A%2F%2Fwww.diabetesmine.com%2F2009%2F04%2Fanother-view-confessions-of-an-uncontrolled-diabetic.html I’ve been accused more than once of being too chipper about my diabetes.  Heck — I have created “the sunny yellow blog,” after all.  So when I received the following email this week, I sat back in my seat and took a deep breath.  Writing a book about how much diabetes sucks certainly isn’t all [...] (Source: Diabetes Mine) Diabetes Mine blogs http://www.medworm.com/rss/comments.php?id=2325199 Thu, 02 Apr 2009 21:02:40 +0100 2325199 http://www.medworm.com/index.php?rid=2134822&cid=t_135852_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2Fk5n1HQOj_qg%2F As we get older we are less likely to throw things away. This was a great problem with my mother, if she couldn’t use something well maybe someone else could. I remember going into her medicine chest to get an aspirin and all of these bottles fell out, scary isn’t it? Upon looking at her medications, I found that some were outdated others written by different doctors, they were also purchased at different pharmacies. I had to convince her to let me toss the outdated medications, we also called the doctors and pharmacies to see if she was putting herself in harms way. If you see more then one doctor you should always supply them with a complete list of your medications. The list needs to include vitamins as well as herbs, because they may react to other prescriptions, always use the sa... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2134822 Mon, 26 Jan 2009 15:00:00 +0100 2134822 http://www.medworm.com/index.php?rid=1825429&cid=t_135852_86_f&fid=36669&url=http%3A%2F%2Ffadelibrary.wordpress.com%2F2008%2F09%2F24%2Fnice-to-meet-you-to-meet-you-latest-nice-guidance%2F Attention deficit hyperactivity disorder (ADHD) Chronic Kidney Disease Identifying and supporting people most at risk of dying prematurely Venous Thromboembolism - dabigatran Influenza (prophylaxis) - zanamivir, amantadine and oseltamivir Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy Balloon catheter dilation of paranasal sinus ostia for chronic sinusitis Posted in NHS, Quality   Tagged: Clinical Guidelines, Diabetes, Drug Therapy, Hyperactivity, Influenza, Kidney Diseases, Mortality, Surgery, Thromboembolism, Transplantation Services    (Source: Fade Library) Fade Library blogs http://www.medworm.com/rss/comments.php?id=1825429 Wed, 24 Sep 2008 10:50:16 +0100 1825429 http://www.medworm.com/index.php?rid=1472375&cid=t_135852_86_f&fid=36669&url=http%3A%2F%2Ffadelibrary.wordpress.com%2F2008%2F05%2F28%2Fnicely-nicely-latest-guidance-from-nice%2F Anaemia (cancer-treatment induced) - epoetin (alfa & beta) & darbepoetin (TA) Adalimumab, etanercept and infliximab for ankylosing spondylitis Type 2 Diabetes (review) (CG) Lipid Modification (CG) Canaloplasty for primary open angle glaucoma (IP) Endoaortic balloon occlusion for cardiac surgery (IP) Single incision mid-urethral tape insertion for stress urinary incontinence in women (IP) Workplace physical activity (PH) (Source: Fade Library) Fade Library blogs http://www.medworm.com/rss/comments.php?id=1472375 Wed, 28 May 2008 11:19:59 +0100 1472375 http://www.medworm.com/index.php?rid=869561&cid=t_135852_133_f&fid=35096&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2F156073869%2F Long Island pediatrician, allergist and immunologist, Dr. Marvin Boris, has been using two diabetes drugs, Actos and Avandia, to treat autistic children. As noted in today’s Newsday, researchers in the Journal of the American Medical Association have found that one of the medications, GlaxoSmithKline’s “controversial diabetes drug” Avandia, appears to raise patients’ risk of heart risk. The Wall Street Journal has the full story about the study on Avandia, and also another study on Actos, made by Takeda Pharmeceutical Company, which suggests that this medication is safer on the heart. Nonetheless, both medications carry the Food and Drug Administration’s toughest warning. Notes Newsday: Dr. Sonal Singh, who led one of the studies reported today, said bot... Autism Vox blogs http://www.medworm.com/rss/comments.php?id=869561 Fri, 14 Sep 2007 00:23:39 +0100 869561 http://www.medworm.com/index.php?rid=650899&cid=t_135852_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F31%2Fcervical-cancer-vaccine-cervarix-slowed-by-fda%2F Filed under: Drug, Prevention, Cervical CancerThe Food an Drug Administration is not going to grant a priority review to GlaxoSmithKline's experimental cancer vaccine Cervarix. Adding pressure is recent controversy surrounding its diabetes drug Avandia. Cervarix will now have to go through a standard 10-month review, instead of going the fast-track route. GlaxoSmithKline is defending its diabetes drug after a study published in the New England Journal of Medicine said that those taking the drug are at greater risks of heart attacks. GlaxoSmithKline expects to market the drug Cervarix in the United States sometime in 2008. Read | Permalink | Email this | Linking Blogs | Comments (Source: The Cancer Blog) The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=650899 Thu, 31 May 2007 04:00:00 +0100 650899 http://www.medworm.com/index.php?rid=631576&cid=t_135852_87_f&fid=34866&url=http%3A%2F%2Fwww.thecardioblog.com%2F2007%2F05%2F23%2Favandia-and-avandamet-tied-to-heart-risks%2F Filed under: Drugs, Daily newsIn a scary bit of news that affects more than 6 million Americans, a drug commonly used to treat diabetes has been linked to increased risk for heart attacks and death. The drug, sold as Avandia or Avandamet, has been on the market for 8 years and has been widely used by diabetes patients to help control blood sugar levels. This is even more concerning due the fact that diabetes patients are already at risk for heart problems without possibly making things worse by using medication that is supposed to be helping, not hurting, their health.Experts warn that people shouldn't panic and stop taking any prescription medication suddenly, but should instead visit with their doctor about any changes that may need to be made.Read | Permalink | Email... The Cardio Blog blogs http://www.medworm.com/rss/comments.php?id=631576 Wed, 23 May 2007 04:00:00 +0100 631576 http://www.medworm.com/index.php?rid=623480&cid=t_135852_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F18%2Fdiabetes-drug-may-be-fast-tracked-for-breast-cancer%2F Filed under: Breast Cancer, Drug, Research, Daily newsDrugs currently in trials for obesity and diabetes may soon be fast-tracked for use in the fight against breast cancer. Typically, it takes many years to research and develop new drugs. But these already-developed drugs, if successful, could reach the market much quicker.The drugs, believed to work by blocking the enzyme PTP1B, could help breast cancer patients because the enzyme is found in high levels in about 40 percent of these patients.Studies on mice show blocking production of the enzyme significantly slowed tumor development. In some cases, it stopped the spread of the cancer and it might even stop some tumors from forming.This is "very important and surprising," says one researcher who remarked that the excitement over this dis... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=623480 Fri, 18 May 2007 04:00:00 +0100 623480